172 related articles for article (PubMed ID: 21651381)
1. The power and the promise of liver cancer stem cell markers.
Liu LL; Fu D; Ma Y; Shen XZ
Stem Cells Dev; 2011 Dec; 20(12):2023-30. PubMed ID: 21651381
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review).
Song K; Wu J; Jiang C
Oncol Rep; 2013 Jan; 29(1):3-12. PubMed ID: 23076400
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.
Chiba T; Kamiya A; Yokosuka O; Iwama A
Cancer Lett; 2009 Dec; 286(2):145-53. PubMed ID: 19464789
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter.
Salnikov AV; Kusumawidjaja G; Rausch V; Bruns H; Gross W; Khamidjanov A; Ryschich E; Gebhard MM; Moldenhauer G; Büchler MW; Schemmer P; Herr I
Cancer Lett; 2009 Mar; 275(2):185-93. PubMed ID: 19026485
[TBL] [Abstract][Full Text] [Related]
5. Liver cancer stem cells: implications for a new therapeutic target.
Lee TK; Castilho A; Ma S; Ng IO
Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
[TBL] [Abstract][Full Text] [Related]
6. Research progress and prospects of markers for liver cancer stem cells.
Zhu CP; Wang AQ; Zhang HH; Wan XS; Yang XB; Chen SG; Zhao HT
World J Gastroenterol; 2015 Nov; 21(42):12190-6. PubMed ID: 26576103
[TBL] [Abstract][Full Text] [Related]
7. Insights into the cell of origin in breast cancer and breast cancer stem cells.
Lindeman GJ; Visvader JE
Asia Pac J Clin Oncol; 2010 Jun; 6(2):89-97. PubMed ID: 20565420
[TBL] [Abstract][Full Text] [Related]
8. Clonogenically Culturing and Expanding CD34+ Liver Cancer Stem Cells in Vitro.
Park SC; Zeng C; Tschudy-Seney B; Nguyen NT; Eun JR; Zhang Y; Ramsamooj R; Zhang Y; Zhao M; Theise ND; Zhou H; Zern MA; Duan Y
Stem Cells Dev; 2015 Jul; 24(13):1506-14. PubMed ID: 25867583
[TBL] [Abstract][Full Text] [Related]
9. Stem-like cells in hepatitis B virus-associated cirrhotic livers and adjacent tissue to hepatocellular carcinomas possess the capacity of tumorigenicity.
Sun YL; Yin SY; Xie HY; Zhou L; Xue F; Wu LM; Gao F; Zheng SS
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1280-6. PubMed ID: 18466286
[TBL] [Abstract][Full Text] [Related]
10. Biology of hepatic cancer stem cells.
Tong CM; Ma S; Guan XY
J Gastroenterol Hepatol; 2011 Aug; 26(8):1229-37. PubMed ID: 21557770
[TBL] [Abstract][Full Text] [Related]
11. Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies.
Liu YC; Yeh CT; Lin KH
Cells; 2020 May; 9(6):. PubMed ID: 32466488
[TBL] [Abstract][Full Text] [Related]
12. Oxytetracycline have the therapeutic efficiency in CD133
Song Y; Kim IK; Choi I; Kim SH; Seo HR
Sci Rep; 2018 Oct; 8(1):16100. PubMed ID: 30382122
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells.
Wilson GS; Hu Z; Duan W; Tian A; Wang XM; McLeod D; Lam V; George J; Qiao L
Stem Cells Dev; 2013 Oct; 22(19):2655-64. PubMed ID: 23638793
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization.
Tirino V; Desiderio V; Paino F; De Rosa A; Papaccio F; La Noce M; Laino L; De Francesco F; Papaccio G
FASEB J; 2013 Jan; 27(1):13-24. PubMed ID: 23024375
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
[TBL] [Abstract][Full Text] [Related]
16. Surface markers of hepatocellular cancer stem cells and their clinical potential.
Feng D; Wang N; Hu J; Li W
Neoplasma; 2014; 61(5):505-13. PubMed ID: 24712843
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cell markers in common cancers - therapeutic implications.
Klonisch T; Wiechec E; Hombach-Klonisch S; Ande SR; Wesselborg S; Schulze-Osthoff K; Los M
Trends Mol Med; 2008 Oct; 14(10):450-60. PubMed ID: 18775674
[TBL] [Abstract][Full Text] [Related]
18. Significance of CD90+ cancer stem cells in human liver cancer.
Yang ZF; Ho DW; Ng MN; Lau CK; Yu WC; Ngai P; Chu PW; Lam CT; Poon RT; Fan ST
Cancer Cell; 2008 Feb; 13(2):153-66. PubMed ID: 18242515
[TBL] [Abstract][Full Text] [Related]
19. CD34(+) Liver Cancer Stem Cells Were Formed by Fusion of Hepatobiliary Stem/Progenitor Cells with Hematopoietic Precursor-Derived Myeloid Intermediates.
Zeng C; Zhang Y; Park SC; Eun JR; Nguyen NT; Tschudy-Seney B; Jung YJ; Theise ND; Zern MA; Duan Y
Stem Cells Dev; 2015 Nov; 24(21):2467-78. PubMed ID: 26192559
[TBL] [Abstract][Full Text] [Related]
20. The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.
Fábián Á; Vereb G; Szöllősi J
Cytometry A; 2013 Jan; 83(1):62-71. PubMed ID: 22997049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
